Bolivia's Vice President David Choquehuanca and six members of the cabinet have tested positive for COVID-19, it was announced Tuesday.
Argentine Health Authorities have decided Tuesday that from now on, people who have taken three doses of a COVID-19 vaccine and remain asymptomatic following close contact with a positive case of the disease shall no longer be required to isolate themselves.
A team of surgeons at the University of Maryland Medical School announced on Monday they had implanted the heart of a genetically modified pig into a human being. Considered a world first, doctors hailed the transplant a historic milestone.
Effective Jan. 12, the Government of Paraguay will require at least two doses of a COVID-19 vaccine to anyone who wishes to enter the country, it was announced, except for people who have been treated with single-dose drugs.
Multiple cases of COVID-19 are leaving companies understaffed but when it comes down to airline services it becomes far more notorious because scores of angry passengers fill airports everywhere.
An Australian Circuit Court Monday ruled in favor of reinstating tennis' top player Novak Djokovic his visa, which was canceled by immigration officials on the grounds that he was not vaccinated against COVID-19.
With 18% of its crews on sick leave due to COVID-19, Latam Airlines Colombia has been forced to cancel some 53 domestic flights between Jan. 8 and 16. Most of the cases were said to be of the Omicron variant.
Cypriot health researchers have warned about the existence of yet a new variant of SARS-CoV-2, known as Deltacron, a combination of the relatively new Delta and Omicron strains. According to the scientists, the new variant has the omicron genetic signature and the delta genomes.
Chile's Medical College said that the coronavirus situation in Argentina was critical as a result of the Omicron variant and advised against traveling to the neighboring country.
Brazil's National Health Surveillance Agency (Anvisa) Friday approved the first nationally manufactured COVID-19 vaccine. The body is also considering a second pediatric drug after having cleared Pfizer's for children aged 5 to 11.